|
Volumn 325, Issue 7376, 2002, Pages 1348-
|
Antithrombotic therapy in acute coronary syndromes
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DALTEPARIN;
ENOXAPARIN;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
HIRUDIN;
LAMIFIBAN;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
NADROPARIN;
PLACEBO;
THROMBIN INHIBITOR;
TICLOPIDINE;
TIROFIBAN;
WARFARIN;
XIMELAGATRAN;
FIBRINOLYTIC AGENT;
ANGINA PECTORIS;
ANTICOAGULANT THERAPY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
COST EFFECTIVENESS ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG INDICATION;
FIBRINOLYTIC THERAPY;
GASTROINTESTINAL TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MORTALITY;
MULTICENTER STUDY;
NEUTROPENIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
THROMBOCYTOPENIA;
THROMBOSIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
CORONARY ARTERY THROMBOSIS;
METHODOLOGY;
ANTICOAGULANTS;
CORONARY THROMBOSIS;
FIBRINOLYTIC AGENTS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
THROMBOLYTIC THERAPY;
|
EID: 0037038784
PISSN: 09598138
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.325.7376.1348 Document Type: Article |
Times cited : (34)
|
References (0)
|